Global
Business Overview
Agenda
 UGP Total 2012 Achievements.
 UGP 2012 Sectors Achievements & Sectors
Comparison.
 2012 Strong Points.
 Sales Team Power & Analysis.
 Plan of Success
UGP Total 2012 Achievements
0
5
10
15
20
25
30
35
40
Q1 108% Q2 94% Q3 92% Total 91%
10.36
18.36
27.36
35.70
9.56
19.54
29.81
39.26
Millions
Achiev.
Target
UGP ICU 2012 Achievements
0
1
1
2
2
3
3
4
4
5
5
Total 36%
1.71
4.71
Millions
Achiev.
Target
UGP Onco 2012 Achievements
0
5
10
15
20
25
30
35
Q1 119% Q2 103% Q3 100% Total 98%
9.97
17.69
28.01
33.99
8.40
17.18
29.17
34.56
Millions
Achiev.
Target
UGP Sectors Comparison / Budget
Onco
88%
ICU
12%
Onco
ICU
UGP Total Sectors Comparison / Achievement
Onco
95%
ICU
5%
Onco
ICU
UGP Total Sectors Comparison / Expenses
Onco
48%
ICU
52%
Onco
ICU
2012 and 2013 Strong Points
 MOH tender award (Irino , Oxali , Cyt ).
 NCI tender award ( Oxal , all items except gem ).
 Another tender award like ismaillia university
Military , seka el-Hadid , monofia university , asuit.
 ICU challenge 2013.
 Devices challenge 2013.
 New blood human resources to private focus.
Successes Ladder
0
5
10
15
20
25
30
35
40
45
50
06 07 08 09 10 11 12 13
8.40
17.70
24.08
35.70
16.00
23.20
30.40
47.50
Millions
Last
This
Sales Team Power & Analysis
 Now we have 23 candidate sales team.
 Secretary & Coordinator 2.
 Medical Representatives & Product Specialist 11.
 Sales Team 4.
 Product Manager 1.
 District Manager 3.
 Marketing Manager 1.
 G. M. 1.
UGP Business Overveiw

UGP Business Overveiw

  • 1.
  • 2.
    Agenda  UGP Total2012 Achievements.  UGP 2012 Sectors Achievements & Sectors Comparison.  2012 Strong Points.  Sales Team Power & Analysis.  Plan of Success
  • 3.
    UGP Total 2012Achievements 0 5 10 15 20 25 30 35 40 Q1 108% Q2 94% Q3 92% Total 91% 10.36 18.36 27.36 35.70 9.56 19.54 29.81 39.26 Millions Achiev. Target
  • 4.
    UGP ICU 2012Achievements 0 1 1 2 2 3 3 4 4 5 5 Total 36% 1.71 4.71 Millions Achiev. Target
  • 5.
    UGP Onco 2012Achievements 0 5 10 15 20 25 30 35 Q1 119% Q2 103% Q3 100% Total 98% 9.97 17.69 28.01 33.99 8.40 17.18 29.17 34.56 Millions Achiev. Target
  • 6.
    UGP Sectors Comparison/ Budget Onco 88% ICU 12% Onco ICU
  • 7.
    UGP Total SectorsComparison / Achievement Onco 95% ICU 5% Onco ICU
  • 8.
    UGP Total SectorsComparison / Expenses Onco 48% ICU 52% Onco ICU
  • 9.
    2012 and 2013Strong Points  MOH tender award (Irino , Oxali , Cyt ).  NCI tender award ( Oxal , all items except gem ).  Another tender award like ismaillia university Military , seka el-Hadid , monofia university , asuit.  ICU challenge 2013.  Devices challenge 2013.  New blood human resources to private focus.
  • 10.
    Successes Ladder 0 5 10 15 20 25 30 35 40 45 50 06 0708 09 10 11 12 13 8.40 17.70 24.08 35.70 16.00 23.20 30.40 47.50 Millions Last This
  • 11.
    Sales Team Power& Analysis  Now we have 23 candidate sales team.  Secretary & Coordinator 2.  Medical Representatives & Product Specialist 11.  Sales Team 4.  Product Manager 1.  District Manager 3.  Marketing Manager 1.  G. M. 1.